To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of priority antimicrobial products through the award of a transferable exclusivity extension period, and for other purposes.

USA115^th CongressHR-6294| House

| Updated: 6/28/2018

Re-Valuing Anti-Microbial Products Act of 2018 or the REVAMP Act This bill amends the Federal Food, Drug, and Cosmetic Act to provide for an award of 12 additional months of market exclusivity to a drug manufacturer for a drug designated as a "priority antimicrobial product." (A priority antimicrobial product is intended to treat or prevent a disease attributable to a multi-drug resistant bacterial or fungal pathogen for which there is a critical unmet medical need.)

View Full Text

Health

Advisory bodiesCongressional oversightDrug safety, medical device, and laboratory regulationDrug therapyGovernment studies and investigationsHealth promotion and preventive careInfectious and parasitic diseasesIntellectual propertyLicensing and registrationsPrescription drugs

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of priority antimicrobial products through the award of a transferable exclusivity extension period, and for other purposes.

USA115^th CongressHR-6294| House

| Updated: 6/28/2018

View Full Text

John Shimkus

Republican Representative

Illinois

Cosponsors (2)

Tony Cárdenas (Democratic)Anna G. Eshoo (Democratic)

Energy and Commerce Committee

Health

Introduced
In Committee
On Floor
Passed Chamber
Enacted

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of priority antimicrobial products through the award of a transferable exclusivity extension period, and for other purposes.

Suggested Questions

Health

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of priority antimicrobial products through the award of a transferable exclusivity extension period, and for other purposes.

Suggested Questions

John Shimkus

Energy and Commerce Committee

Health

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of priority antimicrobial products through the award of a transferable exclusivity extension period, and for other purposes.

Suggested Questions

Health

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of priority antimicrobial products through the award of a transferable exclusivity extension period, and for other purposes.

Suggested Questions

John Shimkus

Energy and Commerce Committee

Health